This study is testing a new medicine, LX9211, to see if it can help reduce pain from Diabetic Peripheral Neuropathic Pain (DPNP). DPNP is a type of nerve pain that people with diabetes can experience. The study will compare LX9211 to a placebo, which is a fake treatment that looks like the real medicine but doesn't have any active ingredients. You can learn more about the study by visiting this website.
Key Points:
- The study is for adults aged 18 or older who have had DPNP for at least 6 months.
- Participants should not have other painful conditions or use certain pain medications before joining.
- Participants must agree to follow study rules and will receive information about any benefits or risks.